Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 712

Similar articles for PubMed (Select 18250288)

1.

Sumatriptan normalizes the migraine attack-related increase in brain serotonin synthesis.

Sakai Y, Dobson C, Diksic M, Aubé M, Hamel E.

Neurology. 2008 Feb 5;70(6):431-9. doi: 10.1212/01.wnl.0000299095.65331.6f.

PMID:
18250288
2.
3.
4.

Alpha[11C] methyl-L-typtophan positron emission tomography in patients with alternating hemiplegia of childhood.

Pfund Z, Chugani DC, Muzik O, Juhász C, Behen ME, Lee J, Chakraborty P, Mangner T, Chugani HT.

J Child Neurol. 2002 Apr;17(4):253-60.

PMID:
12088079
5.

The biology of serotonin receptors: focus on migraine pathophysiology and treatment.

Hamel E.

Can J Neurol Sci. 1999 Nov;26 Suppl 3:S2-6. Review.

PMID:
10563226
6.

Measurement of brain regional alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression.

Rosa-Neto P, Diksic M, Okazawa H, Leyton M, Ghadirian N, Mzengeza S, Nakai A, Debonnel G, Blier P, Benkelfat C.

Arch Gen Psychiatry. 2004 Jun;61(6):556-63.

PMID:
15184235
7.
8.

α-[11C] methyl-L tryptophan-PET as a surrogate for interictal cerebral serotonin synthesis in migraine without aura.

Sakai Y, Nishikawa M, Diksic M, Aubé M.

Cephalalgia. 2014 Mar;34(3):165-73. doi: 10.1177/0333102413506126. Epub 2013 Sep 20.

PMID:
24057438
9.

Increasing blood oxygen increases an index of 5-HT synthesis in human brain as measured using alpha-[(11)C]methyl-L-tryptophan and positron emission tomography.

Nishikawa M, Kumakura Y, Young SN, Fiset P, Vogelzangs N, Leyton M, Benkelfat C, Diksic M.

Neurochem Int. 2005 Dec;47(8):556-64. Epub 2005 Sep 12.

PMID:
16157418
10.

Sumatriptan and cerebral blood flow velocity changes during migraine attacks.

Totaro R, De Matteis G, Marini C, Baldassarre M, Carolei A.

Headache. 1997 Nov-Dec;37(10):635-9.

PMID:
9439084
11.

Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors.

Jakubowski M, Levy D, Goor-Aryeh I, Collins B, Bajwa Z, Burstein R.

Headache. 2005 Jul-Aug;45(7):850-61.

PMID:
15985101
12.

Improvements in health-related quality of life with sumatriptan treatment for migraine.

Jhingran P, Cady RK, Rubino J, Miller D, Grice RB, Gutterman DL.

J Fam Pract. 1996 Jan;42(1):36-42.

PMID:
8537803
13.
14.

Brain stem activation in spontaneous human migraine attacks.

Weiller C, May A, Limmroth V, Jüptner M, Kaube H, Schayck RV, Coenen HH, Diener HC.

Nat Med. 1995 Jul;1(7):658-60.

PMID:
7585147
15.

Clarification of developing and established clinical allodynia and pain-free outcomes.

Landy SH, McGinnis JE, McDonald SA.

Headache. 2007 Feb;47(2):247-52.

PMID:
17300364
17.

Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.

Mathew NT, Landy S, Stark S, Tietjen GE, Derosier FJ, White J, Lener SE, Bukenya D.

Headache. 2009 Jul;49(7):971-82. doi: 10.1111/j.1526-4610.2009.01458.x. Epub 2009 May 27.

PMID:
19486178
18.

Hypothalamic activation in spontaneous migraine attacks.

Denuelle M, Fabre N, Payoux P, Chollet F, Geraud G.

Headache. 2007 Nov-Dec;47(10):1418-26.

PMID:
18052951
19.

Cerebral blood flow during migraine attacks without aura and effect of sumatriptan.

Ferrari MD, Haan J, Blokland JA, Arndt JW, Minnee P, Zwinderman AH, Pauwels EK, Saxena PR.

Arch Neurol. 1995 Feb;52(2):135-9.

PMID:
7848120
20.

Sumatriptan-nonresponders: a survey in 366 migraine patients.

Visser WH, de Vriend RH, Jaspers NH, Ferrari MD.

Headache. 1996 Sep;36(8):471-5.

PMID:
8824001
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk